Dupilumab Improves Symptom Control, Health-Related Quality of Life and Work Productivity Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-Up Results From the RELIEVE-AD Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s598, 2025. DOI: 10.25251/2a8shm52. Disponível em: https://skin.dermsquared.com/skin/article/view/3844. Acesso em: 21 apr. 2026.